Carestream Health has agreed to sell its healthcare information systems (HCIS) business to Royal Philips. Carestream’s HCIS business unit provides imaging IT solutions to multi-site hospitals, radiology services providers, imaging centers, and specialty medical clinics worldwide.
As a result of this acquisition, Philips’ expanded healthcare IT business will feature Carestream’s enterprise imaging platform—including best in class VNA, diagnostic and enterprise viewers, multimedia reporting, workflow orchestrator and clinical, operational, and business analytics tools—as part of its broad portfolio.
“We have had global success in providing radiology and enterprise imaging IT systems to help medical professionals provide quality care and enhance their operations,” says Ludovic d’Aprea, Carestream’s general manager for healthcare information solutions. “By becoming part of Philips, the HCIS business will have a greater opportunity to thrive and grow. Customers will have access to a broader portfolio of healthcare IT solutions to simplify medical image management, enable effective collaboration, and enhance patient care.”
Robert Cascella, chief business leader precision diagnosis, Royal Philips, also spoke out about the acquisition, commenting: “The combination of our successful innovations in imaging system platforms, workflow optimization and artificial intelligence-enabled informatics, combined with Carestream’s cloud-based enterprise imaging informatics platform and complementary geographic footprint will provide a solid foundation to deliver on the promise of precision diagnosis.”
Carestream will retain its medical imaging, dental and industrial films, non-destructive testing, and precision coating businesses, which are not impacted by the sale. “These established businesses have solid financial foundations, innovative technology platforms and have earned the trust of loyal customers around the world,” says David C. Westgate, chairman, president and CEO of Carestream. “Our focus will be on delivering innovation that is life changing—for patients, customers, channel partners, communities and other stakeholders—and we will grow the company for long-term success.”
Additional terms of the transaction were not disclosed.
